We are able to bring an extensive range of experience in drug
development across a broad range of therapeutic areas. Our perspectives
are also tempered with strong business expertise and a growing network
of contacts within the financial sector.
• Expert Opinion on overall development
and clinical aspects for drug licensing;
• Overview and consultation on investment opportunities.